Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2026-01-24 @ 5:05 AM
Study NCT ID:
NCT05396833
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-26
First Post:
2022-05-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)
Sponsor:
EMD Serono Research & Development Institute, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-07
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04-03
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-24
First Submit QC Date:
None
Study First Post Date:
2022-05-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-25
Last Update Post Date:
2025-09-26
Last Update Post Date Type:
ESTIMATED